Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 18 ($0.24) and traded as high as GBX 20 ($0.26). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.24), with a volume of 73,672 shares.
Biodexa Pharmaceuticals Price Performance
The stock has a market capitalization of £31.20 million, a price-to-earnings ratio of -21.95 and a beta of 1.22. The company has a quick ratio of 5.28, a current ratio of 5.28 and a debt-to-equity ratio of 9.52. The business’s 50-day moving average is GBX 18 and its two-hundred day moving average is GBX 18.
Biodexa Pharmaceuticals Company Profile
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
See Also
- Five stocks we like better than Biodexa Pharmaceuticals
- Stock Sentiment Analysis: How it Works
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Investing In Automotive Stocks
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Pros And Cons Of Monthly Dividend Stocks
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
